A detailed history of First Trust Advisors LP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, First Trust Advisors LP holds 44,393 shares of IART stock, worth $963,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,393
Previous 476,555 90.68%
Holding current value
$963,772
Previous $13.9 Million 94.2%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.14 - $31.74 $7.41 Million - $13.7 Million
-432,162 Reduced 90.68%
44,393 $806,000
Q2 2024

Aug 13, 2024

BUY
$23.14 - $34.72 $1.89 Million - $2.83 Million
81,571 Added 20.65%
476,555 $13.9 Million
Q1 2024

May 13, 2024

SELL
$33.4 - $45.2 $5.57 Million - $7.54 Million
-166,916 Reduced 29.71%
394,984 $14 Million
Q4 2023

Feb 13, 2024

SELL
$34.21 - $44.59 $2.92 Million - $3.81 Million
-85,392 Reduced 13.19%
561,900 $24.5 Million
Q3 2023

Nov 13, 2023

BUY
$37.8 - $45.97 $15 Million - $18.3 Million
397,110 Added 158.73%
647,292 $24.7 Million
Q2 2023

Aug 14, 2023

SELL
$37.95 - $58.98 $587,010 - $912,302
-15,468 Reduced 5.82%
250,182 $10.3 Million
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $8.03 Million - $9.24 Million
-152,677 Reduced 36.5%
265,650 $15.3 Million
Q4 2022

Feb 09, 2023

BUY
$42.17 - $58.6 $5.83 Million - $8.11 Million
138,315 Added 49.4%
418,327 $23.5 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $2.48 Million - $3.35 Million
58,545 Added 26.44%
280,012 $11.9 Million
Q2 2022

Aug 12, 2022

BUY
$53.86 - $66.52 $279,856 - $345,637
5,196 Added 2.4%
221,467 $12 Million
Q1 2022

May 13, 2022

BUY
$62.86 - $69.24 $4.6 Million - $5.07 Million
73,217 Added 51.18%
216,271 $13.9 Million
Q4 2021

Feb 08, 2022

SELL
$62.47 - $73.25 $3.98 Million - $4.67 Million
-63,758 Reduced 30.83%
143,054 $9.58 Million
Q3 2021

Nov 15, 2021

BUY
$64.97 - $76.19 $1.38 Million - $1.62 Million
21,308 Added 11.49%
206,812 $14.2 Million
Q2 2021

Aug 16, 2021

BUY
$66.79 - $76.63 $11.8 Million - $13.5 Million
176,402 Added 1938.06%
185,504 $12.7 Million
Q1 2021

May 14, 2021

BUY
$62.63 - $71.15 $570,058 - $647,607
9,102 New
9,102 $629,000
Q3 2020

Nov 05, 2020

SELL
$43.33 - $51.72 $1.09 Million - $1.3 Million
-25,205 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$41.42 - $55.57 $666,282 - $893,899
16,086 Added 176.4%
25,205 $1.18 Million
Q1 2020

May 06, 2020

SELL
$36.67 - $61.04 $1.38 Million - $2.29 Million
-37,582 Reduced 80.47%
9,119 $407,000
Q4 2019

Feb 03, 2020

BUY
$55.73 - $62.49 $927,235 - $1.04 Million
16,638 Added 55.34%
46,701 $2.72 Million
Q3 2019

Nov 04, 2019

SELL
$53.29 - $64.59 $9.66 Million - $11.7 Million
-181,236 Reduced 85.77%
30,063 $1.81 Million
Q2 2019

Jul 30, 2019

BUY
$46.45 - $55.85 $8.85 Million - $10.6 Million
190,626 Added 922.1%
211,299 $11.8 Million
Q1 2019

May 09, 2019

SELL
$42.97 - $57.33 $22.9 Million - $30.5 Million
-531,876 Reduced 96.26%
20,673 $1.15 Million
Q4 2018

Feb 07, 2019

BUY
$42.62 - $64.51 $6.94 Million - $10.5 Million
162,829 Added 41.78%
552,549 $24.9 Million
Q3 2018

Oct 25, 2018

BUY
$57.63 - $65.87 $18.5 Million - $21.2 Million
321,619 Added 472.27%
389,720 $25.7 Million
Q2 2018

Aug 02, 2018

BUY
$54.05 - $67.23 $3.68 Million - $4.58 Million
68,101 New
68,101 $4.39 Million
Q1 2018

Apr 23, 2018

SELL
$46.55 - $57.38 $878,817 - $1.08 Million
-18,879 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$46.22 - $51.77 $1.49 Million - $1.67 Million
-32,205 Reduced 63.04%
18,879 $904,000
Q3 2017

Oct 24, 2017

BUY
$47.8 - $53.63 $2.44 Million - $2.74 Million
51,084
51,084 $2.58 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.81B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.